Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
Endocrine Agents
|
Endocrine Agents
|
|
Hypolipidemics
|
Hypolipidemics
|
|
Hypolipidemics can be divided into 5 different categories. What are they?
|
Statins,
Fibric Acid Derivatives, Niacin, Resins, Cholesterol Absorption Inhibitors |
|
Statins (Atorva~, Prava~, Simva~, Fluva~, Lova~, Rosuva~)
1) What is the CU of statins? 2) MOA of statins? 3) AEs / CIs of statins? |
1) TX of choice for hypercholesterolemia in pts @ risk for CAD -->
Dec risk of MI & stroke and dec CV mortality Large dec LDL Med dec TGs Small inc HDL 2) Inhibs HMG-CoA reductase in liver --> No chol synth in liver --> Forces hepatocytes to upreg LDL receptors --> Inc Hepatic LDL Catab AND Inc extraction of VLDL (LDL precursor) from circulation 3) AEs: Inc transaminases (Liver); Inc creatine kinase; Symptomatic hepatitis; Symptomatic myopathy (ask about leg cramps) CIs: Liver Dz; CI'ed w/ concurrent use of gemfibrozil (inc risk myopathy) |
|
Fibric Acid Derivatives (Gemfibrozil)
1) CU of gemfibrozil? 2) MOA of gemfibrozil? 3) AEs / CIs of gemfibrozil? 4) 2 PK / PD points for gemfibrozil? ***NOTE: -Fenofibrate is similar to gemfibrozil but causes great inc HDL -Clofibrate is less well tolerated than gemfibrozil |
1) Hypertriglyceridemia!!
Large dec TGs Med inc HDL Small dec TC and LDL 2) Binds nuclear transcription regulator PPAR-alpha --> Inc LPL --> Dec TGs by dec'ing VLDL and apo-CIII 3) AEs: GI distress; rash; myopathy; gallstones CI: Hepatic dysfnctn; Renal dysfnctn 4) Potentiates effects of warfarin and sulfonylureas like Glyburide |
|
Niacin (B3)
1) CU of Niacin? 2) MOA of Niacin? 3) AEs / CIs? |
1) Hypercholesterolemia w/ concomitant inc TGs;
Low HDL 2) Inhibs Hormone Sensitive Lipase in adipose --> Dec lipolysis of TGs --> Dec FA to liver --> Dec hepatic synth of TGs Dec peripheral LP lipase --> Dec TGs Large dec TGs Med inc HDL Medium dec TC and LDL 3) AEs: Flushing that can be prevented by taking ASA before; Pruritus; GI distress, glucose intolerance, inc Transaminases, Hyperuricemia, Gout, Amblyopia |
|
Resins (Cholestyramine)
1) CU of Cholestyramine? 2) MOA of Cholestyramine? 3) AEs and CIs of Cholestyramine? |
1) 2nd line (behind statins) for Hypercholesterolemia
Large Nothing Medium dec in TC and LDL Small inc HDL and TGs 2) Binds bile acids in intestine --> Inhibits enterohepatic circulation of bile acids --> Inc excretion of bile acids --> Inc conversion of cholesterol into bile acids in liver --> Upregulation and subsequent inc clearance of LDL from plasma 3) AEs: Bloating and other GI CIs: Hypertriglyceridemia ***Other resins include: Colestipol & Colsevelam |
|
Cholesterol Absorption Inhibitors (Ezetimibe)
1) CU of Ezetimibe? 2) MOA of Ezetimibe? 3) AEs / CIs of Ezetimibe? |
1) w/ a statin for hypercholesterolemia
Dec TC and LDL 2) Inhibs intestinal cholesterol absorption in jejunum 3) AEs: URIs; slight inc risk of transaminitis when given w/ statin |
|
Hypoglycemics
|
Hypoglycemics
|
|
What are the 7 classes of hypoglycemics?
|
Insulin
Sulfonylureas Meglitinides GLP-1 Analogs Biguanides TZDs alpha-glucosidase inhibitors |
|
Insulin
1) What is the CU of insulin 2) MOA of insulin? 3) AEs / CI's of Insulin? ***NOTE: Pramlintide is an amylin analog. Amylin is a peptide hormone co-secreted w/ insulin from pancreas --> Dec Gastric emptying and Inhib Glucagon secretion. |
1) Glucose CTL in diabetics:
Req'd in Type I, Used in Type II if glucose cannot be well CTL'ed w/ oral agents w/ Glucose for life-threatening hyperkalemia 2) -Liver: Stims Glycogenesis; Inhibs Glycogenolysis; Inhibs Gluconeogenesis -Muscle: Glucose and K uptake -Adipose: Stims glucose uptake into adipocytes 3) Hypoglycemia |
|
Sulfonylureas (Glyburide)
1) CU of Sulfonylureas? 2) MOA of Sulfonylureas? 3) AEs & CIs of Sulfonylureas? |
1) T II DM if glucose cannot be CTL'ed w/ diet and metformin
2) Blocks K+ channels on pancreatic beta cell --> Dec K+ Efflux --> Inc IC K+ --> Depolarization of pancreatic beta-cell --> Ca Influx --> Insulin Release 3) Hypoglycemia |
|
Meglitinides (Starlix)
1) CU of Meglitinides? 2) MOA of Meglitinides? 3) AEs / CIs of Meglitinides? |
1) TII DM (3rd Line)
2) Same as Sulfonylureas EXCEPT has a more rapid onset and a shorter duration 3) Hypoglycemia |
|
GLP-1 Analog (Glucagon-like Peptide 1 Analog) (Exenatide)
1) CU of GLP-1 Analog? 2) MOA of GLP-1 Analog? 3) AEs / CIs of GLP-1 Analog? |
1) TII DM if can't CTL glucose w/ diet and metformin
2) Binds GLP-1 receptors on pancreatic beta cells --> Stim Adenylate Cyclase --> Inc cAMP --> Inc Insulin Synthesis Secretion 3) -Hypoglycemia if given concurrentlyw/ a Sulfonylurea -Nausea |
|
BIguanides (Metformin)
1) CU of Biguanides? 2) MOA of Biguanides? 3) AEs / CIs of Biguanides? |
1) 1st line Tx for TII DM
2) Inhibs hepatic gluconeogenesis 3) GI Upset |
|
TZDs (Rosiglitazone)
1) CU of TZDs? 2) MOA of TZDs? 3) AEs / CIs of TZDs? |
1) TII DM (If no glucose CTL w/ diet and metformin)
2) Binds PPAR-gamma --> Cells are more sensitized insulin 3) Hepatotoxic |
|
alpha-glucosidase Inhibitors (Acarbose)
1) CU of alpha-glucosidase Inhibitors? 2) MOA of alpha-glucosidase Inhibitors? 3) AEs / CIs of alpha-glucosidase inhibitors? |
1) TII DM (3rd Line)
2) Inhibs metab of carbohydrates 3) ABD Pain |